SPETCA: Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Recruiting
CT.gov ID
NCT04864626
Collaborator
(none)
250
1
34.5
7.2

Study Details

Study Description

Brief Summary

The referral center for eating disorders provides for a systematic many years follow-up of patients under care with an annual assessment at the center. The investigators have recently shown the frequency of relapse in the first 7 years after diagnosis, but the literature remains poor on this epidemiology and on the risk factors for relapse. The investigators would therefore like to extend this follow-up for an additional 3 years after remission with an annual telephone nursing interview for all cured patients.

Condition or Disease Intervention/Treatment Phase
  • Other: semi-standardized interview
  • Other: care experience questionary

Study Design

Study Type:
Observational
Anticipated Enrollment :
250 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center
Actual Study Start Date :
Jun 16, 2021
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
patient with eating disorder

Other: semi-standardized interview
annual collection of the number of consultations and hospitalizations at the center, as well as the number of treatments

Other: care experience questionary
questionary with 12 questions to rate the quality of the telephone reception and your feelings during the interview

Outcome Measures

Primary Outcome Measures

  1. Number of relapses/recurrences per year [3 years]

Secondary Outcome Measures

  1. risk factors for relapse/recurrence [3 years]

    To determinate if one or more factors below could be a risk factors for relapse/recurrence : Age Sex Body mass index Contraception use History of an eating disorder Intense physical activity History of psychiatric hospitalization History of suicide attempt Presence of psychotropic treatment of any kind

  2. Number of patients called per year [3 years]

  3. Number of calls made per patient per year [3 years]

  4. Number of completed calls per patient per year [3 years]

  5. Number of telephone sessions per year per patient [3 years]

  6. Duration of telephone sessions [3 years]

  7. Number of lost to follow-up per year [3 years]

  8. Number of patients not cured [3 years]

  9. Analysis of the experience of care questionnaire [3 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients diagnosed with an eating disorder confirmed at the multidisciplinary consultation meeting of the referring center and considered cured (in remission). For patients with Oral Disorders, inclusion is within one year of recovery

  • Patient affiliated or entitled to a social security plan

  • Oral participation agreement

Exclusion Criteria:
  • Pregnant

  • Persons deprived of liberty

  • Patients under guardianship or curatorship

  • refusal to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU de SAINT-ETIENNE Saint-etienne France 42000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: Marion POY, CHU Saint Etienne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT04864626
Other Study ID Numbers:
  • 19PH227
  • 2020-A02830-39
First Posted:
Apr 29, 2021
Last Update Posted:
Apr 4, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 4, 2022